Electronic cigarettes
Electronic cigarettes has been studied in 37 papers since 2021: 1 trial and 16 observational studies in people, 19 reviews; 28 in the past year. The newest paper, Oct 16, 2026: “The effects of electronic nicotine delivery systems on metabolic markers - a systematic review”.
37 papers study it30 findingsUpdated
See all 36 papers on electronic cigarettes
At a glance
Human studies link electronic cigarettes with oxidative stress and respiratory disease; independent labs report the oxidative-stress association. Reviews describe smoking-cessation benefits but disagree on hypertension, with a review showing no clear effect for exclusive use. Authors include company employees, and papers declare company ties.
30 findings in 19 papers from 2021 to 2026, 5 of them since June 2026
Independent labs found the same change in people. 13 independent labs in 10 countries.
“At 8 weeks, 7-day PPA did not differ significantly between e-cigarette and NRT groups [25 (14.3%) of 175 and 17 (9.7%) of 175, respectively; OR 1.56; 95% CI 0.80-3.04; p = 0.19].”
2 of its findings point the other way.
- 13 independent labs in 10 countries
- 2 findings against
- Funders: National Institute for Health Research and others
- 5 of 24 findings with company ties
- Human trial1
- Humans16
- In silico1
What did studies of electronic cigarettes find?
16Studies of electronic cigarettes measured 16 outcomes; the most studied is smoking cessation (3 studies).
Smoking cessation
upin humans3OR 1.17–1.67
3 studies
Smoking cessation
upin humans3OR 1.17–1.67
Electronic cigarettes are linked with better smoking cessation in humans (smoking cessation attempt) (ORadj = 1.50 [0.96-2.34]).
“E-cigarettes appeared to be effective for helping older adults to stop smoking (ORadj = 1.50 [0.96-2.34])”
Humanssmoking cessation attempt
BMC medicine
Electronic cigarettes improve smoking cessation in humans (compared with FDA-approved nicotine replacement therapies).
“E-cigarettes with nicotine are less harmful than cigarettes and have been shown to be more effective for smoking cessation than US Food and Drug Administration-approved nicotine replacement therapies.”
Reviewcompared with FDA-approved nicotine replacement therapieswith nicotine
Nicotine E-Cigarettes for Cigarette Smoking Cessation: Recommendations to US-Based Clinicians
JAMA
Electronic cigarettes increase smoking cessation in humans (versus other interventions) (RR/OR 1.17-1.67 vs NRT, 1.46-2.09 vs non-nicotine EC).
“all reported point estimates favouring nicotine EC for smoking cessation”
Reviewversus other interventions
Addiction (Abingdon, England)
Augmentation index
upin humans1
1 study
Augmentation index
upin humans1
Electronic cigarettes increase augmentation index in humans (nicotine-containing products exposure) (SMD=1.05 [95% CI: 0.34-1.76, p=0.008]).
“The AIx analysis included 9 studies (n=190) and also demonstrated a significant increase (SMD=1.05 [95% CI: 0.34-1.76, p=0.008]).”
Reviewnicotine-containing products exposuren = 190
Current cardiology reviews
Pulse wave velocity
upin humans1
1 study
Pulse wave velocity
upin humans1
Electronic cigarettes increase pulse wave velocity in humans (nicotine-containing products exposure) (SMD=1.71 [95% CI: 0.23-3.19, p=0.031]).
“The PWV analysis included 6 studies (n=133) and demonstrated a significant increase following exposure to nicotine-containing products (SMD=1.71 [95% CI: 0.23-3.19, p=0.031]).”
Reviewnicotine-containing products exposuren = 133
Current cardiology reviews
Hypertension
no changein humans1OR 1.09
1 study
Hypertension
no changein humans1OR 1.09
Electronic cigarettes showed no clear effect on hypertension in humans (exclusive e-cigarette use) (OR 1.09, 95% CI 0.88-1.36).
“the pooled estimate for exclusive e-cigarette use included the null (OR 1.09, 95% CI 0.88-1.36; I2 = 68.1%)”
Reviewexclusive e-cigarette use
American journal of preventive cardiology
Adverse events
no changein humans1
1 study
Adverse events
no changein humans1
Electronic cigarettes showed no clear effect on adverse events in humans (nicotine EC vs other interventions).
“For adverse events, pooled estimates generally indicated little or no difference between groups.”
Reviewnicotine EC vs other interventions
Addiction (Abingdon, England)
Stroke
upin reviews1
1 study
Stroke
upin reviews1
Electronic cigarettes increase stroke under ischemic conditions.
“impaired cerebral glucose transport, particularly under ischemic conditions, resulting in exacerbated stroke severity”
Reviewunder ischemic conditions
Uncovering the neurophysiological parallels between vaping and traditional cigarette smoking
Discover Neuroscience
Blood-brain barrier permeability
upin reviews1
1 study
Blood-brain barrier permeability
upin reviews1
Electronic cigarettes increase blood-brain barrier permeability.
“e-cigarette exposure consistently downregulated BBB tight junction proteins (ZO-1, claudin-3) and increased permeability, oxidative stress, and inflammatory markers”
Review
Uncovering the neurophysiological parallels between vaping and traditional cigarette smoking
Discover Neuroscience
Oxidative stress and ROS signaling
upin humans1
1 study
Oxidative stress and ROS signaling
upin humans1
Electronic cigarettes are linked with oxidative stress and ROS signaling in humans.
“Elevated IFN-γ and MDA levels indicated increased inflammation and oxidative stress in vapers.”
Humans
Impact of E-Cigarette Use on Circadian Proteins and Cardiovascular Risk Markers
Journal of cardiovascular translational research
Inflammation
upin humans1
1 study
Inflammation
upin humans1
Electronic cigarettes are linked with inflammation in humans.
“Elevated IFN-γ and MDA levels indicated increased inflammation and oxidative stress in vapers.”
Humans
Impact of E-Cigarette Use on Circadian Proteins and Cardiovascular Risk Markers
Journal of cardiovascular translational research
Circadian clock
downin humans1
1 study
Circadian clock
downin humans1
Electronic cigarettes are linked with circadian clock in humans.
“Vaping significantly decreased Melatonin, PER1, PER2, CRY1, and CRY2, while BMAL1 remained unchanged.”
Humans
Impact of E-Cigarette Use on Circadian Proteins and Cardiovascular Risk Markers
Journal of cardiovascular translational research
Smoking behavior
downin humans1
1 study
Smoking behavior
downin humans1
Electronic cigarettes decrease smoking behavior in humans (recent failed quit attempt).
“Both groups showed similar reductions in cigarette use and dependence.”
Human trialrecent failed quit attempt8 weeksn = 350
Lancet regional health. Americas
Smoking abstinence
no changein humans1OR 1.56
1 study
Smoking abstinence
no changein humans1OR 1.56
Electronic cigarettes showed no clear effect on smoking abstinence in humans (recent failed quit attempt) (14.3% vs 9.7%; OR 1.56, 95% CI 0.80-3.04, p = 0.19).
“At 8 weeks, 7-day PPA did not differ significantly between e-cigarette and NRT groups [25 (14.3%) of 175 and 17 (9.7%) of 175, respectively; OR 1.56; 95% CI 0.80-3.04; p = 0.19].”
Human trialrecent failed quit attemptJUUL e-cigarettes vs nicotine patch and lozenge8 weeksn = 350
Lancet regional health. Americas
All 16Fewer
What is electronic cigarettes linked with?
12Studies link electronic cigarettes with 12 measures, among them asthma, smoking prevalence and coronary artery disease.
Asthma
upin humans1
1 study
Asthma
upin humans1
Electronic cigarettes raise the risk of asthma in humans (epidemiologic and experimental studies).
“A growing body of experimental and epidemiologic evidence has implicated e-cigarette use in the pathogenesis of respiratory diseases such as chronic obstructive pulmonary disease, lung cancer, interstitial lung disease, and asthma.”
Reviewepidemiologic and experimental studies
Use of electronic cigarettes and asthma across the lifespan
The Journal of allergy and clinical immunology
Smoking prevalence
downin humans1
1 study
Smoking prevalence
downin humans1
Electronic cigarettes are associated with smoking prevalence in humans following regulatory clarification and endorsement as a cessation aid (below 7%).
“from 2018/19, smoking prevalence declined rapidly, coinciding with increased uptake of vaping following regulatory clarification and their endorsement as a cessation aid.”
Reviewfollowing regulatory clarification and endorsement as a cessation aid
New Zealand's accelerating smoking decline: lessons for tobacco harm reduction
The Lancet regional health. Western Pacific
Coronary artery disease
upin humans1OR 1.19
1 study
Coronary artery disease
upin humans1OR 1.19
Electronic cigarettes raise the risk of coronary artery disease in humans (OR = 1.19, p < 0.0001).
“significantly higher pooled odds of coronary heart disease (OR = 1.19, p < 0.0001)”
Review
BMC public health
Stroke
upin humans1OR 1.62
1 study
Stroke
upin humans1OR 1.62
Electronic cigarettes raise the risk of stroke in humans (OR = 1.62, p < 0.01).
“stroke (OR = 1.62, p < 0.01)”
Review
BMC public health
Major adverse cardiovascular events
upin humans1OR 1.57
1 study
Major adverse cardiovascular events
upin humans1OR 1.57
Electronic cigarettes raise the risk of major adverse cardiovascular events in humans (OR = 1.57, p < 0.0001).
“major adverse cardiovascular events (MACE) (OR = 1.57, p < 0.0001)”
Review
BMC public health
Hypertension
upin humans1
1 study
Hypertension
upin humans1
Electronic cigarettes raise the risk of hypertension in humans.
“current evidence suggests significant adverse cardiovascular effects, including an increased risk of hypertension.”
Review
Impact of electronic cigarette use on blood pressure: A systematic review
Heart & lung : the journal of critical care
Age-related macular degeneration
no changein humans1OR 1.08
1 study
Age-related macular degeneration
no changein humans1OR 1.08
Electronic cigarettes are associated with age-related macular degeneration in humans (OR 1.08 (95% CI, 0.73 to 1.60)).
“1.08 (95% CI, 0.73 to 1.60) in adults who used e-cigarettes, compared to those who had never used these products.”
Humansn = 26,689
Journal of vitreoretinal diseases
Oxidative stress and ROS signaling
upin humans1
1 study
Oxidative stress and ROS signaling
upin humans1
Electronic cigarettes are associated with oxidative stress and ROS signaling in humans (former smokers).
“EC smoking was related to higher vascular stiffness and oxidative stress, although to a lesser degree compared to conventional cigarette smoking.”
Reviewformer smokers
Cureus
Arterial stiffness
upin humans1
1 study
Arterial stiffness
upin humans1
Electronic cigarettes are associated with arterial stiffness in humans (former smokers).
“The overall analysis demonstrated that EC smoking was related to higher vascular stiffness and oxidative stress, although to a lesser degree compared to conventional cigarette smoking.”
Reviewformer smokers
Cureus
Cardiovascular risk
upin humans1
1 study
Cardiovascular risk
upin humans1
Electronic cigarettes are associated with cardiovascular risk in humans (former smokers) (r = 0.60, 95% CI: 0.45-0.81).
“The total effect size indicated a positive but moderate relationship (r = 0.60, 95% CI: 0.45-0.81) between EC smoking and cardiovascular risks.”
Reviewformer smokers
Cureus
All 12Fewer
Funding
4 grants since 2018National Cancer Institute$3.3MNational Institute on Drug Abuse$2.3MNational Institute for Health Research£390K
National Institute on Drug AbuseMedical University of South Carolina$668K2024–2029
National Cancer InstituteUniversity of Tx Md Anderson Can Ctr$672K2020–2027
Does Switching to Nicotine-containing Electronic Cigarettes Reduce Health Risk Markers?
National Institute on Drug AbusePennsylvania State Univ Hershey Med Ctr$761K2018–2024
National Institute for Health ResearchLondon South Bank University£390K2018–2020
Contains public sector information licensed under the Open Government Licence v3.0.
How this record changed
Summary rewritten as its findings changed.
As it read before
Human reviews describe increased augmentation index and pulse wave velocity with nicotine-containing electronic cigarettes, no hypertension effect with exclusive use, and smoking prevalence below 7% following regulatory clarification and cessation-aid endorsement. Work spans two independent labs in two countries; GlaxoSmithKline funds one finding, and a paper declares an interest of the product's maker.
Summary written from the findings.